Related Experiment Video
Updated: Aug 11, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Hormone-related headache: pathophysiology and treatment
Avi Ashkenazi1, Stephen D Silberstein
1Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. avi.ashkenazi@jefferson.edu
CNS Drugs
|February 16, 2006
Summary
Female sex hormones significantly influence migraine prevalence and presentation. Estrogen impacts pain perception, leading to higher migraine rates in women, especially around menstruation and menopause.
Area of Science:
- Neurology
- Endocrinology
- Pain Management
Background:
- Migraine prevalence differs significantly between sexes, with higher rates in postpubertal females.
- Estrogen levels are known to affect brain functions, including pain perception, linking them to migraine.
- Hormonal fluctuations throughout a woman's life, including menstruation, pregnancy, and menopause, impact migraine patterns.
Purpose of the Study:
- To explore the intricate relationship between female sex hormones and migraine.
- To review the impact of hormonal changes on migraine frequency, severity, and treatment.
- To discuss the implications of hormonal therapies and contraceptives on migraine management.
Main Methods:
- Review of epidemiological data and existing literature on migraine and female hormones.
- Analysis of migraine patterns related to the menstrual cycle, pregnancy, and menopause.
- Evaluation of treatment strategies and risks associated with hormonal interventions.
Main Results:
- Migraine is more prevalent in females post-puberty and often linked to the perimenstrual period.
- Hormonal contraceptive use and hormone replacement therapy (HRT) can alter migraine characteristics and carry stroke risks.
- Migraine generally improves during pregnancy but may worsen postpartum; menopause often sees a decrease, though perimenopause can be challenging.
Conclusions:
- Female sex hormones play a crucial role in migraine pathophysiology and clinical presentation.
- Management of migraine in women requires careful consideration of hormonal status and associated risks.
- Personalized treatment strategies are essential, particularly concerning hormonal therapies and contraception.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...